快速訂購

HSPD1/HSP60  抗體

All HSPD1 Reagents

反應性: Human  
應用 : WB  IF  IP  ICC/IF  
101240-T38-50
101240-T38-200
101240-T38-100
50 µg 
200 µg 
100 µg 
Add to Cart
  • Slide 1
  • Slide 1
  • Slide 1
反應性: Mouse  
應用 : WB  IHC-P  IP  
50596-T44-50
50596-T44-200
50596-T44-100
50 µg 
200 µg 
100 µg 
Add to Cart
  • Slide 1
  • Slide 1
  • Slide 1
  • Slide 1
反應性: Mouse  
應用 : ELISA  WB  IHC-P  IP  
50596-RP02-50
50596-RP02-200
50596-RP02-100
50 µg 
200 µg 
100 µg 
Add to Cart
  • Slide 1
  • Slide 1
  • Slide 1
  • Slide 1
  • Slide 1
反應性: Mouse  
應用 : IHC-P  
50596-RP01-400
50596-RP01-200
50596-RP01-100
400 µg 
200 µg 
100 µg 
Add to Cart
  • Slide 1
  • Slide 1

Browse HSPD1/HSP60 Products by

HSPD1/HSP60 相关研究领域

HSPD1/HSP60 相關信號通路

    HSPD1/HSP60 概述&蛋白信息

    HSPD1/HSP60 研究背景

    基因概述: HSPD1 gene encodes a member of the chaperonin family. The encoded mitochondrial protein may function as a signaling molecule in the innate immune system. This protein is essential for the folding and assembly of newly imported proteins in the mitochondria. This HSP60 is adjacent to a related family member and the region between the 2 genes functions as a bidirectional promoter. Several pseudogenes have been associated with HSPD1 gene. Two transcript variants encoding the same protein have been identified for HSPD1 gene. Mutations associated with HSPD1 gene cause autosomal recessive spastic paraplegia 13. [provided by RefSeq, Jun 2010]
    General information above from NCBI
    亞單位結構: Interacts with HRAS (By similarity). Interacts with HBV protein X and HTLV-1 protein p40tax. Interacts with ATAD3A. Interacts with METTL20 and METTL21B. {ECO:0000250, ECO:0000269|PubMed:15120623, ECO:0000269|PubMed:1731090, ECO:0000269|PubMed:22664726, ECO:0000269|PubMed:23349634}.
    亞細胞定位: Mitochondrion matrix.
    相關疾病 : DISEASE: Spastic paraplegia 13, autosomal dominant (SPG13) [MIM:605280]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:11898127}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukodystrophy, hypomyelinating, 4 (HLD4) [MIM:612233]: A severe autosomal recessive hypomyelinating leukodystrophy. Clinically characterized by infantile-onset rotary nystagmus, progressive spastic paraplegia, neurologic regression, motor impairment, profound mental retardation. Death usually occurs within the first two decades of life. {ECO:0000269|PubMed:18571143}. Note=The disease is caused by mutations affecting the gene represented in this entry.
    相似的序列: Belongs to the chaperonin (HSP60) family. {ECO:0000305}.
    General information above from UniProt

    HSPD1, also known as HSP60, is a member of the chaperonin family. HSPD1 may function as a signaling molecule in the innate immune system. This protein is essential for the folding and assembly of newly imported proteins in the mitochondria. It may also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix. HSPD1 gene is adjacent to a related family member and the region between the 2 genes functions as a bidirectional promoter. Several pseudogenes have been associated with this gene. Mutations associated with this gene cause autosomal recessive spastic paraplegia 13.Defects in HSPD1 are a cause of spastic paraplegia autosomal dominant type 13 (SPG13). Spastic paraplegia is a degenerative spinal cord disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Defects in HSPD1 are the cause of leukodystrophy hypomyelinating type 4 (HLD4); also called mitochondrial HSP60 chaperonopathy or MitCHAP-60 disease. HLD4 is a severe autosomal recessive hypomyelinating leukodystrophy. HSPD1 is cinically characterized by infantile-onset rotary nystagmus, progressive spastic paraplegia, neurologic regression, motor impairment, profound mental retardation. Death usually occurrs within the first two decades of life.

    Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy

    HSPD1/HSP60 別稱

    HLD4,CPN60,GROEL,HSP60,HSP65,SPG13,HSP-60,HuCHA60, [homo-sapiens]
    CPN60,GROEL,HLD4,HSP60,HSP65,HSPD1,HuCHA60,SPG13, [human]
    Hsp60,Hspd1,60kDa, [mouse]
    60kDa,Hsp60, [mus-musculus]
    Hsp60,Hspd1-30p, [Rat]

    HSPD1/HSP60 相關文獻

  • Hansen J J, et al. (2002) Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet. 70: 1328-32.
  • Magen D, et al. (2008) Mitochondrial Hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet. 83: 30-42.
  • Venner TJ, et al. (1990) Nucleotide sequences and novel structural features of human and Chinese hamster hsp60 (chaperonin) gene families. DNA Cell Biol. 9 (8): 545-52.
  • 請注意:所有產品都是“僅用於科研,而不能用於診斷或治療用途”